The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis

A. A. Amato, K. Kagan-Hallet, C. E. Jackson, S. Lampkin, G. I. Wolfe, Mark Ferrante, E. H. Bigio, R. J. Barohn

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: Myofibrillar myopathy (MFM) is characterized by nonhyaline lesions (foci of myofibrillar destruction) and hyaline lesions (cytoplasmic inclusions composed of compacted myofibrillar residues) on light and electron microscopy. Immunocytochemistry demonstrates the abnormal expression of desmin and numerous other proteins. The clinical, laboratory, and histologic features of MFM are heterogeneous, making a diagnosis difficult Results: We diagnosed eight patients with MFM over the preceding 3 years. MFM was inherited in an autosomal dominant pattern in one patient, developed sporadically in five patients, and was induced by an experimental chemotherapy, Elinafide (Knoll, Parsippany, NJ), in two patients. Age at onset ranged from 14 to 64 years. The pattern of weakness was variable but involved proximal and distal muscles. Five patients had evidence of a cardiomyopathy. Electromyography demonstrated muscle membrane instability and small, polyphasic motor unit potentials. Serum creatine kinase levels were normal to moderately elevated (<10 x normal). Light and electron microscopy demonstrated the characteristic pattern of nonhyaline and hyaline lesions and the associated abnormalities on immunocytochemistry. Conclusions: Patients demonstrate a wide spectrum of clinical, laboratory, and histologic abnormalities. Chemotherapy-induced MFM has abnormalities on immunocytochemistry similar to the those of hereditary and sporadic cases. The pathogenesis of MFM is likely heterogeneous. However, MFM is distinctive in that it can preferentially affect distal muscles and has a frequent association with cardiomyopathy. The cardiomyopathy may be amenable to treatment with pacemaker insertion or cardiac transplantation.

Original languageEnglish (US)
Pages (from-to)1646-1655
Number of pages10
JournalNeurology
Volume51
Issue number6
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Cardiomyopathies
Hyalin
Immunohistochemistry
Muscles
Electron Microscopy
Light
Drug Therapy
Desmin
Inclusion Bodies
Electromyography
Heart Transplantation
Creatine Kinase
Myofibrillar Myopathy
Age of Onset
Membranes
Serum
Proteins
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Amato, A. A., Kagan-Hallet, K., Jackson, C. E., Lampkin, S., Wolfe, G. I., Ferrante, M., ... Barohn, R. J. (1998). The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis. Neurology, 51(6), 1646-1655. https://doi.org/10.1212/WNL.51.6.1646

The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis. / Amato, A. A.; Kagan-Hallet, K.; Jackson, C. E.; Lampkin, S.; Wolfe, G. I.; Ferrante, Mark; Bigio, E. H.; Barohn, R. J.

In: Neurology, Vol. 51, No. 6, 01.01.1998, p. 1646-1655.

Research output: Contribution to journalArticle

Amato, AA, Kagan-Hallet, K, Jackson, CE, Lampkin, S, Wolfe, GI, Ferrante, M, Bigio, EH & Barohn, RJ 1998, 'The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis', Neurology, vol. 51, no. 6, pp. 1646-1655. https://doi.org/10.1212/WNL.51.6.1646
Amato, A. A. ; Kagan-Hallet, K. ; Jackson, C. E. ; Lampkin, S. ; Wolfe, G. I. ; Ferrante, Mark ; Bigio, E. H. ; Barohn, R. J. / The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis. In: Neurology. 1998 ; Vol. 51, No. 6. pp. 1646-1655.
@article{0c29d4c26dc446c48d0494762062e194,
title = "The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis",
abstract = "Background: Myofibrillar myopathy (MFM) is characterized by nonhyaline lesions (foci of myofibrillar destruction) and hyaline lesions (cytoplasmic inclusions composed of compacted myofibrillar residues) on light and electron microscopy. Immunocytochemistry demonstrates the abnormal expression of desmin and numerous other proteins. The clinical, laboratory, and histologic features of MFM are heterogeneous, making a diagnosis difficult Results: We diagnosed eight patients with MFM over the preceding 3 years. MFM was inherited in an autosomal dominant pattern in one patient, developed sporadically in five patients, and was induced by an experimental chemotherapy, Elinafide (Knoll, Parsippany, NJ), in two patients. Age at onset ranged from 14 to 64 years. The pattern of weakness was variable but involved proximal and distal muscles. Five patients had evidence of a cardiomyopathy. Electromyography demonstrated muscle membrane instability and small, polyphasic motor unit potentials. Serum creatine kinase levels were normal to moderately elevated (<10 x normal). Light and electron microscopy demonstrated the characteristic pattern of nonhyaline and hyaline lesions and the associated abnormalities on immunocytochemistry. Conclusions: Patients demonstrate a wide spectrum of clinical, laboratory, and histologic abnormalities. Chemotherapy-induced MFM has abnormalities on immunocytochemistry similar to the those of hereditary and sporadic cases. The pathogenesis of MFM is likely heterogeneous. However, MFM is distinctive in that it can preferentially affect distal muscles and has a frequent association with cardiomyopathy. The cardiomyopathy may be amenable to treatment with pacemaker insertion or cardiac transplantation.",
author = "Amato, {A. A.} and K. Kagan-Hallet and Jackson, {C. E.} and S. Lampkin and Wolfe, {G. I.} and Mark Ferrante and Bigio, {E. H.} and Barohn, {R. J.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1212/WNL.51.6.1646",
language = "English (US)",
volume = "51",
pages = "1646--1655",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis

AU - Amato, A. A.

AU - Kagan-Hallet, K.

AU - Jackson, C. E.

AU - Lampkin, S.

AU - Wolfe, G. I.

AU - Ferrante, Mark

AU - Bigio, E. H.

AU - Barohn, R. J.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Background: Myofibrillar myopathy (MFM) is characterized by nonhyaline lesions (foci of myofibrillar destruction) and hyaline lesions (cytoplasmic inclusions composed of compacted myofibrillar residues) on light and electron microscopy. Immunocytochemistry demonstrates the abnormal expression of desmin and numerous other proteins. The clinical, laboratory, and histologic features of MFM are heterogeneous, making a diagnosis difficult Results: We diagnosed eight patients with MFM over the preceding 3 years. MFM was inherited in an autosomal dominant pattern in one patient, developed sporadically in five patients, and was induced by an experimental chemotherapy, Elinafide (Knoll, Parsippany, NJ), in two patients. Age at onset ranged from 14 to 64 years. The pattern of weakness was variable but involved proximal and distal muscles. Five patients had evidence of a cardiomyopathy. Electromyography demonstrated muscle membrane instability and small, polyphasic motor unit potentials. Serum creatine kinase levels were normal to moderately elevated (<10 x normal). Light and electron microscopy demonstrated the characteristic pattern of nonhyaline and hyaline lesions and the associated abnormalities on immunocytochemistry. Conclusions: Patients demonstrate a wide spectrum of clinical, laboratory, and histologic abnormalities. Chemotherapy-induced MFM has abnormalities on immunocytochemistry similar to the those of hereditary and sporadic cases. The pathogenesis of MFM is likely heterogeneous. However, MFM is distinctive in that it can preferentially affect distal muscles and has a frequent association with cardiomyopathy. The cardiomyopathy may be amenable to treatment with pacemaker insertion or cardiac transplantation.

AB - Background: Myofibrillar myopathy (MFM) is characterized by nonhyaline lesions (foci of myofibrillar destruction) and hyaline lesions (cytoplasmic inclusions composed of compacted myofibrillar residues) on light and electron microscopy. Immunocytochemistry demonstrates the abnormal expression of desmin and numerous other proteins. The clinical, laboratory, and histologic features of MFM are heterogeneous, making a diagnosis difficult Results: We diagnosed eight patients with MFM over the preceding 3 years. MFM was inherited in an autosomal dominant pattern in one patient, developed sporadically in five patients, and was induced by an experimental chemotherapy, Elinafide (Knoll, Parsippany, NJ), in two patients. Age at onset ranged from 14 to 64 years. The pattern of weakness was variable but involved proximal and distal muscles. Five patients had evidence of a cardiomyopathy. Electromyography demonstrated muscle membrane instability and small, polyphasic motor unit potentials. Serum creatine kinase levels were normal to moderately elevated (<10 x normal). Light and electron microscopy demonstrated the characteristic pattern of nonhyaline and hyaline lesions and the associated abnormalities on immunocytochemistry. Conclusions: Patients demonstrate a wide spectrum of clinical, laboratory, and histologic abnormalities. Chemotherapy-induced MFM has abnormalities on immunocytochemistry similar to the those of hereditary and sporadic cases. The pathogenesis of MFM is likely heterogeneous. However, MFM is distinctive in that it can preferentially affect distal muscles and has a frequent association with cardiomyopathy. The cardiomyopathy may be amenable to treatment with pacemaker insertion or cardiac transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0031700768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031700768&partnerID=8YFLogxK

U2 - 10.1212/WNL.51.6.1646

DO - 10.1212/WNL.51.6.1646

M3 - Article

VL - 51

SP - 1646

EP - 1655

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -